Heron Therapeutics
HRTX
#10276
Rank
C$68.89 M
Marketcap
C$0.36
Share price
-4.39%
Change (1 day)
-76.43%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2026 (TTM): C-$0.26

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is C-$0.27. In 2025 the company made an earnings per share (EPS) of C-$0.17 a decrease over its 2024 EPS that were of C-$0.13.

EPS history for Heron Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.2653.91%
2025C-$0.1733.33%
2024C-$0.13
2022C-$2.48-23.11%
2021C-$3.23-10%
2020C-$3.59-0%
2019C-$3.591.21%
2018C-$3.54
2016C-$6.5254.76%
2015C-$4.221.73%
2014C-$4.14-16.23%
2013C-$4.9591.67%
2012C-$2.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
C-$1.76 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
C$0.50-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$3.71-1,463.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
C-$0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
C-$9.61 3,426.32%๐Ÿ‡บ๐Ÿ‡ธ USA